Literature DB >> 17124160

Molecular basis of Barrett's oesophagus and oesophageal adenocarcinoma.

R C Fitzgerald1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17124160      PMCID： PMC1856460          DOI： 10.1136/gut.2005.089144

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  119 in total

1.  Esophageal adenocarcinoma arising from Barrett's metaplasia has regional variations in the west.

Authors:  Janusz A Jankowski; Dawn Provenzale; Paul Moayyedi
Journal:  Gastroenterology       Date:  2002-02       Impact factor: 22.682

2.  17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus.

Authors:  P C Galipeau; D S Cowan; C A Sanchez; M T Barrett; M J Emond; D S Levine; P S Rabinovitch; B J Reid
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

3.  Dynamic effects of acid on Barrett's esophagus. An ex vivo proliferation and differentiation model.

Authors:  R C Fitzgerald; M B Omary; G Triadafilopoulos
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

Review 4.  p53, the cellular gatekeeper for growth and division.

Authors:  A J Levine
Journal:  Cell       Date:  1997-02-07       Impact factor: 41.582

5.  Beta-catenin expression and its association with prognostic factors in adenocarcinoma developed in Barrett esophagus.

Authors:  Maria-Chiara Osterheld; Yan-Song Bian; Fred T Bosman; Jean Benhattar; Charlotte Fontolliet
Journal:  Am J Clin Pathol       Date:  2002-03       Impact factor: 2.493

6.  Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease.

Authors:  M F Vaezi; J E Richter
Journal:  Gastroenterology       Date:  1996-11       Impact factor: 22.682

Review 7.  The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett.

Authors:  S J Spechler; R K Goyal
Journal:  Gastroenterology       Date:  1996-02       Impact factor: 22.682

8.  [Profile of p53 mutations and abnormal expression of P53 protein in 2 forms of esophageal cancer].

Authors:  F Muzeau; J F Fléjou; F Potet; J Belghiti; G Thomas; R Hamelin
Journal:  Gastroenterol Clin Biol       Date:  1996

9.  Aberrant expression of minichromosome maintenance proteins 2 and 5, and Ki-67 in dysplastic squamous oesophageal epithelium and Barrett's mucosa.

Authors:  J J Going; W N Keith; L Neilson; K Stoeber; R C Stuart; G H Williams
Journal:  Gut       Date:  2002-03       Impact factor: 23.059

10.  Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA.

Authors:  H B El-Serag; A C Mason; N Petersen; C R Key
Journal:  Gut       Date:  2002-03       Impact factor: 23.059
View more
  53 in total

1.  Activation of the BMP4 pathway and early expression of CDX2 characterize non-specialized columnar metaplasia in a human model of Barrett's esophagus.

Authors:  Daniel Castillo; Sonia Puig; Mar Iglesias; Agustín Seoane; Carme de Bolós; Vicente Munitiz; Pascual Parrilla; Laura Comerma; Richard Poulsom; Kausilia K Krishnadath; Luís Grande; Manuel Pera
Journal:  J Gastrointest Surg       Date:  2011-11-11       Impact factor: 3.452

Review 2.  Cdx genes, inflammation, and the pathogenesis of intestinal metaplasia.

Authors:  Douglas B Stairs; Jianping Kong; John P Lynch
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

3.  Toll-like receptor 9 expression in the natural history of Barrett mucosa.

Authors:  Heikki Huhta; Olli Helminen; Joonas H Kauppila; Heikki Takala; Kalervo Metsikkö; Petri Lehenkari; Juha Saarnio; Tuomo Karttunen
Journal:  Virchows Arch       Date:  2015-04-03       Impact factor: 4.064

4.  Interactions between environmental factors and polymorphisms in angiogenesis pathway genes in esophageal adenocarcinoma risk: a case-only study.

Authors:  Rihong Zhai; Yang Zhao; Geoffrey Liu; Monica Ter-Minassian; I-Chen Wu; Zhaoxi Wang; Li Su; Kofi Asomaning; Feng Chen; Matthew H Kulke; Xihong Lin; Rebecca S Heist; John C Wain; David C Christiani
Journal:  Cancer       Date:  2011-07-12       Impact factor: 6.860

5.  Targeted endoscopic imaging.

Authors:  Meng Li; Thomas D Wang
Journal:  Gastrointest Endosc Clin N Am       Date:  2009-04

6.  Association between NQO1 Pro187Ser polymorphism and esophageal cancer: a meta-analysis.

Authors:  Kai Liu; Hui Tian; Kai-Zhong Yu; Wei-Yu Shen; Zhen-Chun Mao; Chen-Hua Jin; Hai-Bin Pan; Jin-Xian He
Journal:  Tumour Biol       Date:  2013-11-10

7.  Vitamin D Receptor Polymorphisms Are Associated with Reduced Esophageal Vitamin D Receptor Expression and Reduced Esophageal Adenocarcinoma Risk.

Authors:  Vincent T Janmaat; Anouk Van De Winkel; Maikel P Peppelenbosch; Manon C W Spaander; André G Uitterlinden; Farzin Pourfarzad; Hugo W Tilanus; Agnieszka M Rygiel; Leon M G Moons; Pascal P Arp; Kausilia K Krishnadath; Ernst J Kuipers; Luc J W Van Der Laan
Journal:  Mol Med       Date:  2015-04-21       Impact factor: 6.354

8.  Polyphenon E inhibits the growth of human Barrett's and aerodigestive adenocarcinoma cells by suppressing cyclin D1 expression.

Authors:  Shumei Song; Koyamangalath Krishnan; Kaifeng Liu; Robert S Bresalier
Journal:  Clin Cancer Res       Date:  2009-01-15       Impact factor: 12.531

Review 9.  History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus.

Authors:  Stuart Jon Spechler; Rebecca C Fitzgerald; Ganapathy A Prasad; Kenneth K Wang
Journal:  Gastroenterology       Date:  2010-01-18       Impact factor: 22.682

10.  Pathogenesis of Barrett's esophagus: bile acids inhibit the Notch signaling pathway with induction of CDX2 gene expression in human esophageal cells.

Authors:  David J Morrow; Nelly E Avissar; Liana Toia; Eileen M Redmond; Thomas J Watson; Carolyn Jones; Dan P Raymond; Virginia Litle; Jeffrey H Peters
Journal:  Surgery       Date:  2009-10       Impact factor: 3.982
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.